ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 360,247 | 311,212 | 285,621 | 262,646 | 217,833 |
| Marketable Securities | 15,626 | 14,885 | 9,131 | 8,859 | 5,718 |
| Receivables | 274,469 | 255,432 | 281,082 | 252,617 | 225,654 |
| Inventories | 143,149 | 143,468 | 143,067 | 146,475 | 138,315 |
| TOTAL | $825,433 | $747,084 | $753,117 | $698,402 | $602,630 |
| Non-Current Assets | |||||
| PPE Net | 73,223 | 67,115 | 62,476 | 63,560 | 59,247 |
| Intangibles | 512,337 | 529,641 | 542,006 | 562,297 | 580,853 |
| Other Non-Current Assets | 83,119 | 78,130 | 82,778 | 83,893 | 100,271 |
| TOTAL | $668,679 | $674,886 | $687,260 | $709,750 | $740,371 |
| Total Assets | $1,494,112 | $1,421,970 | $1,440,377 | $1,408,152 | $1,343,001 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,329 | 19,298 | 17,268 | 15,241 | 13,216 |
| Accounts payable and accrued liabilities | 73,830 | 69,694 | 62,583 | 69,795 | 54,569 |
| Accrued Expenses | 184,964 | 145,221 | 196,022 | 185,456 | 165,273 |
| Other current liabilities | N/A | N/A | N/A | 63 | 483 |
| TOTAL | $283,655 | $239,510 | $278,112 | $270,555 | $236,835 |
| Non-Current Liabilities | |||||
| Long Term Debt | 280,155 | 285,996 | 291,840 | 297,677 | 301,484 |
| Other Non-Current Liabilities | 333,090 | 334,164 | 329,701 | 334,103 | 343,075 |
| TOTAL | $613,245 | $620,160 | $621,541 | $631,780 | $644,559 |
| Total Liabilities | $896,900 | $859,670 | $899,653 | $902,335 | $881,394 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,970 | 22,745 | 22,425 | 22,469 | 21,700 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | 31,104 | 6,393 | -23,099 | -50,589 | -76,862 |
| Other shareholders' equity | -144 | 475 | 784 | 3,173 | 28,568 |
| TOTAL | $597,212 | $562,300 | $540,724 | $505,817 | $461,607 |
| Total Liabilities And Equity | $1,494,112 | $1,421,970 | $1,440,377 | $1,408,152 | $1,343,001 |